Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Endocrine 2CNS 2Other hematologic neoplasm 1NET 1Head & Neck 1

Conditions

Neuroblastoma 2Neoplasms 2Meningioma 2Medulloblastoma 2Thyroid Cancer, Papillary 1Pain 1Neuroendocrine Tumors 1Nausea 1Hematologic Neoplasms 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Whole Body Imaging × Clear all
NCT05024929 2025-11-14

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Children's Hospital of Philadelphia

Recruiting
32 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Neoplasms

NCT05433636 2024-02-06

Mindful Waiting Room

University of Utah

Phase NA Unknown
305 enrolled

Anxiety Disorders, Depression, Fatigue, Nausea, Neoplasms, Pain

NCT03273712 2023-02-09

Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)

University of Iowa

Phase 2 Completed
39 enrolled 9 charts
CNSEndocrineNET

Medulloblastoma, Meningioma, Neuroblastoma, Neuroendocrine Tumors

NCT03611764 2018-10-31

Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers

Washington University School of Medicine

Phase 1 Terminated
37 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT03013387 2017-08-25

Dosimetry Guided PRRT With 90Y-DOTATOC

University of Iowa

Phase 2 Withdrawn
CNS

Medulloblastoma, Meningioma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡